Regulation and targeting of androgen receptor nuclear localization in castration-resistant prostate cancer-Reference-Cited by-同舟云学术

Regulation and targeting of androgen receptor nuclear localization in castration-resistant prostate cancer

Published:2021-02-15 Issue:4 Volume:131 Page:
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:

Author:

Lv Shidong,Song Qiong,Chen Guang,Cheng Erdong,Chen Wei,Cole Ryan,Wu Zeyu,Pascal Laura E.^ORCID,Wang Ke,Wipf Peter^ORCID,Nelson Joel B.,Wei Qiang,Huang Wenhua,Wang Zhou^ORCID

Funder

U.S. Department of Defense

National Institutes of Health

National Cancer Institute

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://www.jci.org/articles/view/141335/files/pdf

Reference66 articles.

1. Cancer statistics, 2020

2. Abiraterone and Increased Survival in Metastatic Prostate Cancer

3. Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy

4. Abiraterone Acetate, A Novel Adrenal Inhibitor in Metastatic Castration-Resistant Prostate Cancer

5. Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. UBX‐390: A Novel Androgen Receptor Degrader for Therapeutic Intervention in Prostate Cancer;Advanced Science;2024-07-03

2. Androgen receptor and estrogen receptor variants in prostate and breast cancers;The Journal of Steroid Biochemistry and Molecular Biology;2024-07

3. A potent new-scaffold androgen receptor antagonist discovered on the basis of a MIEC-SVM model;Acta Pharmacologica Sinica;2024-05-15

4. Androgen deprivation induces double-null prostate cancer via aberrant nuclear export and ribosomal biogenesis through HGF and Wnt activation;Nature Communications;2024-02-09

5. Cytoplasmic Shotgun Proteomic Points to Key Proteins and Pathways in Temozolomide-Resistant Glioblastoma Multiforme;Journal of Proteome Research;2023-12-26